+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Point-of-Care Glucose Testing Market Research Report by Product, Mode of Purchase, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 225 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5305543
UP TO OFF until Dec 31st 2022
The Global Point-of-Care Glucose Testing Market size was estimated at USD 5,818.43 million in 2021, USD 6,241.35 million in 2022, and is projected to grow at a CAGR 7.44% to reach USD 8,952.43 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Point-of-Care Glucose Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, i-STAT, Onetouch Verio Flex, StatStrip, and True Metrix.
  • Based on Mode of Purchase, the market was studied across OTC Testing Product and Prescription-based Testing Product.
  • Based on End User, the market was studied across Home Care Settings, Hospitals & Critical Care Centers, and Outpatient & Ambulatory Care Facilities.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Point-of-Care Glucose Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Point-of-Care Glucose Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Point-of-Care Glucose Testing Market, including Abbott Laboratories, Accubiotech Co. Ltd., ACON Laboratories, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, bioLytical Laboratories Inc., Chembio Diagnostics, Inc, Danaher Corporation, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Fluxergy, LifeScan, Inc. By Platinum Equity, LLC., Medtronic PLC, Nipro Corporation, Nova Biomedical Corporation, OraSure Technologies Inc., Prodigy Diabetes Care, LLC., Quidel Corporation, Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sinocare, Trinity Biotech PLC, Trividia Health, Inc., and Zoetis Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Point-of-Care Glucose Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Point-of-Care Glucose Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Point-of-Care Glucose Testing Market?
4. What is the competitive strategic window for opportunities in the Global Point-of-Care Glucose Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Point-of-Care Glucose Testing Market?
6. What is the market share of the leading vendors in the Global Point-of-Care Glucose Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Point-of-Care Glucose Testing Market?
Frequently Asked Questions about the Global Point-of-Care Glucose Testing Market

What is the estimated value of the Global Point-of-Care Glucose Testing Market?

The Global Point-of-Care Glucose Testing Market was estimated to be valued at $5818.43 Million in 2021.

What is the growth rate of the Global Point-of-Care Glucose Testing Market?

The growth rate of the Global Point-of-Care Glucose Testing Market is 7.4%, with an estimated value of $8952.43 Million by 2027.

What is the forecasted size of the Global Point-of-Care Glucose Testing Market?

The Global Point-of-Care Glucose Testing Market is estimated to be worth $8952.43 Million by 2027.

Who are the key companies in the Global Point-of-Care Glucose Testing Market?

Key companies in the Global Point-of-Care Glucose Testing Market include Abbott Laboratories, Accubiotech Co. Ltd., ACON Laboratories, Inc., Becton, Dickinson, and Company, Bio, Rad Laboratories, bioLytical Laboratories Inc., Chembio Diagnostics, Inc and EKF Diagnostics.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the Prevalence Rate of Diabetic Patients
5.1.1.2. Growing Incorporation of Data Management Programs in the Monitoring of Glucose
5.1.2. Restraints
5.1.2.1. High Cost of Product Development
5.1.3. Opportunities
5.1.3.1. Adoption of Advanced Technology with Smartphone Orientation, Embedded Vision-Based Solutions, and Digital Technologies for Better Testing
5.1.3.2. Growing Demand for Home Healthcare from Developed and Developing Countries
5.1.4. Challenges
5.1.4.1. Potential Interference and Calibration Issues in Glucose Meters
5.2. Cumulative Impact of COVID-19
6. Point-Of-Care Glucose Testing Market, by Product
6.1. Introduction
6.2. Accu Check Aviva Meter
6.3. Accu-Chek Inform Ii
6.4. Bayer Contour Blood Glucose Monitoring System
6.5. Freestyle Lite
6.6. I-Stat
6.7. Onetouch Verio Flex
6.8. Statstrip
6.9. True Metrix
7. Point-Of-Care Glucose Testing Market, by Mode of Purchase
7.1. Introduction
7.2. OTC Testing Product
7.3. Prescription-Based Testing Product
8. Point-Of-Care Glucose Testing Market, by End-user
8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals & Critical Care Centers
8.4. Outpatient & Ambulatory Care Facilities
9. Americas Point-Of-Care Glucose Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Point-Of-Care Glucose Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Point-Of-Care Glucose Testing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Accubiotech Co. Ltd.
13.3. Acon Laboratories, Inc.
13.4. Becton, Dickinson, and Company
13.5. Bio-Rad Laboratories
13.6. Biolytical Laboratories Inc.
13.7. Chembio Diagnostics, Inc
13.8. Danaher Corporation
13.9. Ekf Diagnostics
13.10. F. Hoffmann-La Roche Ltd.
13.11. Fluxergy
13.12. Lifescan, Inc. by Platinum Equity, LLC.
13.13. Medtronic plc
13.14. Nipro Corporation
13.15. Nova Biomedical Corporation
13.16. Orasure Technologies Inc.
13.17. Prodigy Diabetes Care, LLC.
13.18. Quidel Corporation
13.19. Sekisui Diagnostics, LLC
13.20. Siemens Healthineers Ag
13.21. Sinocare
13.22. Trinity Biotech plc
13.23. Trividia Health, Inc.
13.24. Zoetis Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET DYNAMICS
FIGURE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2021 VS 2027 (%)
FIGURE 28. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2021 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2027
FIGURE 30. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 35. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2027
FIGURE 37. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 45. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2027
FIGURE 47. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 53. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2027
FIGURE 55. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 57. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2027
FIGURE 59. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2027
FIGURE 74. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 86. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 87. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 58. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2019-2027 (USD MILLION)
TABLE 59. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 61. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 64. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 66. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 69. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 71. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 76. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 78. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 80. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 81. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 82. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 84. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 85. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 86. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 88. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 89. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 90. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 92. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 93. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 94. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 96. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 97. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 98. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 99. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 102. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 103. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 104. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 106. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 107. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 108. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 110. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 111. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 112. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 114. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 115. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 116. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 118. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 119. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 120. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 121. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 122. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 123. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 124. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 126. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 127. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 128. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 130. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 131. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 132. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 134. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 135. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 136. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 137. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 138. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 139. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 140. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 142. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 143. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 144. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 145. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 146. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 147. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 153. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 154. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 155. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 156. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 157. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 158. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 159. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 160. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 161. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 162. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 163. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 164. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 165. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 166. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 167. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 168. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 169. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 170. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 171. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 172. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 173. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 175. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 176. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 177. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 178. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 179. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 180. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 181. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 182. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 183. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 184. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 185. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 186. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 187. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 188. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 193. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 194. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 195. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2019-2027 (USD MILLION)
TABLE 196. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 197. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 198. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 199. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 200. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET RANKING
TABLE 201. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 202. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET MERGER & ACQUISITION
TABLE 203. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 204. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 205. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET INVESTMENT & FUNDING
TABLE 206. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 207. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Accubiotech Co. Ltd.
  • ACON Laboratories, Inc.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories
  • bioLytical Laboratories Inc.
  • Chembio Diagnostics, Inc
  • Danaher Corporation
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd.
  • Fluxergy
  • LifeScan, Inc. By Platinum Equity, LLC.
  • Medtronic PLC
  • Nipro Corporation
  • Nova Biomedical Corporation
  • OraSure Technologies Inc.
  • Prodigy Diabetes Care, LLC.
  • Quidel Corporation
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • Sinocare
  • Trinity Biotech PLC
  • Trividia Health, Inc.
  • Zoetis Inc.

Methodology

Loading
LOADING...